Pharma Now PR

The Pharma Quality Excellence Awards 2025 Honour Mumbai's Visionaries In Pharmaceutical Innovation

Pharma Quality Excellence Awards 2025 honoured innovation & quality leaders in Mumbai’s pharma industry.

Vaibhavi M. | Apr 30, 2025

AI in Pharma

Pharma Now Launches Its April–May 2025 Edition: A Guide To The Future Of The Pharmaceutical Industry

Pharma Now launches its April–May 2025 magazine packed with expert insights, AI in pharma, regulatory updates, leadership stories & market trends.

Simantini Singh Deo | Apr 30, 2025

Perspective Initiates Early-Stage Study Of FAP-α Targeted Radiopharmaceutical In Cancer Patients

Perspective Therapeutics begins Phase 1/2a trial, dosing first patient with [212Pb]PSV359 to evaluate safety and efficacy in FAP-α solid tumours.

Vaibhavi M. | Apr 30, 2025

Merck Launches Wilmington Biotech Hub To Manufacture KEYTRUDA®, Creating Jobs And Advancing U.S. Biologics Manufacturing

Merck launched a $1B biologics centre in Delaware, which is set to produce KEYTRUDA and next-gen therapies, creating 500+ jobs.

Vaibhavi M. | Apr 30, 2025

AbbVie’s RINVOQ Receives FDA Approval For Treatment Of Giant Cell Arteritis In Adults

AbbVie receives FDA approval for RINVOQ in GCA, supported by intense Phase 3 results showing higher sustained remission vs. placebo.

Vaibhavi M. | Apr 30, 2025

AbbVie’s RINVOQ Receives FDA Approval For Treatment Of Giant Cell Arteritis In Adults

AbbVie receives FDA approval for RINVOQ in GCA, supported by intense Phase 3 results showing higher sustained remission vs. placebo.

Vaibhavi M. | Apr 30, 2025

Sandoz And Henlius Partner On Global Commercialisation Of Ipilimumab Biosimilar

Sandoz signs $301M deal with Henlius for ipilimumab biosimilar rights across the US, EU, Japan, and more, boosting its oncology portfolio.

Vaibhavi M. | Apr 30, 2025